LINC02431

Across TCGA pan-cancer cohorts, LINC02431 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC02431 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC02431 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02431 expression acts as an unfavorable survival marker, although some lineages such as OV and GBM show a favorable association.

UCS, KIRC, and OV are the cancer types where LINC02431 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.135	0.687	.009	72	view →
KIRC	DFS	Tertile	IV	0.209	0.634	.002	54	view →
OV	OS	Tertile	All	0.516	0.310	.019	54	view →
LGG	DFS	Tertile	All	0.513	0.746	.005	18	view →
GBM	OS	Tertile	All	1.000	0.379	.023	15	view →
BRCA	OS	Tertile	II,III,IV	0.791	0.915	.012	12	view →
THYM	OS	Tertile	All	0.381	0.878	.043	6	view →
SKCM	DFS	Tertile	All	0.530	0.761	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC02431–UCS (OS)

Open the UCS breakdown →